Login / Signup

Immunologic evaluation of patients with cefotetan-induced anaphylaxis.

Young Hee NamEui Kyung HwangGa Young BanHyun Jung JinHye Soo YooYoo Seob ShinYoung Min YeDong Ho NahmHae-Sim ParkSoo Keol Lee
Published in: Allergy, asthma & immunology research (2014)
Cefotetan is a commonly prescribed second-generation cephalosporin that acts against a wide range of bacteria. However, cefotetan-induced hypersensitivity has rarely been reported. We report 2 cases of cefotetan-induced anaphylaxis with immunologic evaluation. The first case was a 70-year-old asthmatic woman who had dyspnea and hypotension during administration of cefotetan, in which high serum-specific IgE to cefotetan-human serum albumin (HSA) conjugate was detected by enzyme-linked immunosorbent assay. The second case was a 63-year-old asthmatic woman who complained of chest tightness and dyspnea during cefotetan infusion, in which high serum-specific IgG1 and IgG4 with no serum specific IgE to cefotetan-HSA conjugate was detected. The basophil activation test using basophils from the patient showed a significant up-regulation of CD63 with the addition of anti-IgG4 antibody compared with that in non-atopic healthy controls. In conclusion, cefotetan can induce anaphylaxis, which may involve both IgE- and IgG4-mediated responses in the pathogenic mechanism.
Keyphrases
  • high glucose
  • diabetic rats
  • drug induced
  • case report
  • lung function
  • endothelial cells
  • high throughput
  • cancer therapy